Endometriosis is a disease that is becoming more and more challenging for the medical
community. The current therapeutic concepts (surgical therapy and/or hormonal therapies) …

Introduction Hormonal contraceptives can influence female sexual function. Aim The goal of
this article was to provide a comprehensive review of the effects that various hormonal …

STUDY QUESTION Is there a global consensus on the management of endometriosis that
considers the views of women with endometriosis? SUMMARY ANSWER It was possible to …

Endometriosis is a chronic medical condition that affects around 6% to 10% of reproductive
age women. Pelvic pain, dysmenorrhea, and infertility are the most common presenting …

BACKGROUND Dienogest is a selective progestin that has been investigated in a clinical
trial programme for the treatment of endometriosis. The current non-inferiority trial compared …

Purpose Endometriosis is a prevalent disease that affects 5–15% of women of reproductive
age. The aim of this study is to assess the effect of dienogest in the treatment of …

Objective: Endometriosis affects up to 10% of women of reproductive age, and the main goal
of treatment is to relieve symptoms. Progestins have been the mainstay of endometriosis …

OBJECTIVE: To investigate the efficacy and safety of oral dienogest 2mg compared with
placebo in the treatment of endometriosis-associated pelvic pain (EAPP). STUDY DESIGN …

Purpose To investigate the efficacy and safety of dienogest as a long-term treatment in
endometriosis, with follow-up after treatment discontinuation. The study included women …

Endometriosis can recur after either surgical or medical therapy. Long-term medical therapy
is implemented to treat symptoms or prevent recurrence. Dienogest and gonadotropin …